Influence of Pb&Cd Seminal Plasma Level & ICSI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-01

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the influence of lead (pb) and cadmium (cd) seminal plasma level on embryo development and pregnancy rate during intracytoplasmic sperm injection (ICSI).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ICSI Versus Conventional IVF in Couples With Non-severe Male Infertility

NCT03298633

Male Infertility

COMPLETED NA

Is the Lack of Prior Exposure to Sperm Antigens Associated With Worse Neonatal and Maternal Outcomes?

NCT04852237

Obstructive Azoospermia Obstetric Complication

COMPLETED

Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome

NCT03129243

Infertility, Male

COMPLETED

Epididymal U.S Findings in Asthenozoospermic &Correlation With L.Carnitine Level

NCT05436080

Asthenozoospermia

UNKNOWN

Seminal Level of Clusterin Before Testicular Sperm Extraction

NCT03857828

Azoospermia, Nonobstructive

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The inability to have children, both by natural procreation and medically assisted reproduction, is not only a challenge for medical science but also an economic and social problem. Infertility is a complex disorder with multiple genetic and environmental causes (Gill et al.,2018) One of the factors that may be responsible for this phenomenon is contamination of the environment with heavy metals Two of the most widely-recognized reproductive toxins are lead (Pb) and cadmium (Cd) (Wdowiak et al., 2018).

Food, water and tobacco and smoking are the primary source of baseline exposure to lead and cadmium (Tong et al., 2000; Bernard, 2008) Each of cadmium and lead were inversely correlated with semen parameters as, ejaculate volume, sperm count, sperm concentration, live sperms and rapid mobility. ( Zaki et al.,2018).

Reproductive contaminants found in follicular fluid (FF) and seminal plasma may compromise the quality of oocytes and or sperm, which may become one of the risk factors for reproductive outcome. The data available suggests certain chemicals or their metabolite reaches the seminal plasma and/or FF, indicating their possible impact in In Vitro fertilization (IVF) outcome ,However, more studies are needed with regard to relationship between exposure level and affected parameters. (Kumar et al., 2010).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility, Male

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Isolated male infertility (oligozoospermia, astenozoospermia, teratozoospermia)
* First ICSI cycle
* Female partner ≤ 35 y-old

Exclusion Criteria

* • Wife age \> 35 years

* Frozen semen samples
* Male partner with severe oligoasthenoteratozoospermia \<5 × 106 / mL and 5% progressive motility, included globozoospermia and pinhead samples, and surgically retrieved sperms
* Poor responder women
* Women with abnormal endometrium at hCG trigger day.
* Women with BMI \> 31
* Women with PCOS
* Previous failed ICSI
* OHSS)overian hyperstimulation syndrome)
* Patients with systemic diseases affecting fertility
* Patients on radiotherapy or receiving medications with gonadotoxic effect eg., chemotherapy

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No